$0.26
Live
In the last 1 year, Seagen Inc has given 45.9% return, outperforming this stock by 136.9%
1.15%
Downside
Day's Volatility :9.32%
Upside
8.26%
19.04%
Downside
52 Weeks Volatility :94.95%
Upside
93.76%
Period | APPLIED MOLECULAR TRANSPORT | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -57.13% | 0.7% | -6.8% |
6 Months | -73.38% | -8.3% | -6.0% |
1 Year | -91.04% | -1.9% | -4.6% |
3 Years | -98.52% | 25.3% | 25.9% |
Market Capitalization | 10.1M |
Book Value | $0.92 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -2.81 |
Wall Street Target Price | 0.6 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -47.68% |
Return On Equity TTM | -136.19% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | -42.1M |
EBITDA | -98.2M |
Diluted Eps TTM | -2.81 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.09 |
EPS Estimate Next Year | -0.88 |
EPS Estimate Current Quarter | -0.6 |
EPS Estimate Next Quarter | 0.06 |
What analysts predicted
Upside of 130.77%
Sell
Neutral
Buy
APPLIED MOLECULAR TRANSPORT is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() APPLIED MOLECULAR TRANSPORT | 0.8% | -73.38% | -91.04% | -98.52% | -98.52% |
![]() Moderna, Inc. | -4.27% | -29.63% | -10.94% | 105.39% | 586.61% |
![]() Regeneron Pharmaceuticals, Inc. | -8.82% | -3.37% | 11.63% | 22.7% | 139.69% |
![]() Seagen, Inc. | -1.74% | 61.71% | 45.87% | 23.07% | 217.59% |
![]() Vertex Pharmaceuticals Incorporated | -6.21% | 0.88% | 20.1% | 12.88% | 112.8% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() APPLIED MOLECULAR TRANSPORT | NA | NA | NA | -1.09 | -1.36 | -0.48 | 0.0 | 0.92 |
![]() Moderna, Inc. | 11.46 | 11.46 | 0.0 | -1.9 | 0.27 | 0.12 | 0.0 | 49.12 |
![]() Regeneron Pharmaceuticals, Inc. | 19.72 | 19.72 | 9.01 | 41.59 | 0.19 | 0.1 | 0.0 | 219.38 |
![]() Seagen, Inc. | NA | NA | 18.53 | -2.88 | -0.23 | -0.12 | 0.0 | 14.54 |
![]() Vertex Pharmaceuticals Incorporated | 26.15 | 26.15 | 0.41 | 14.62 | 0.26 | 0.17 | 0.0 | 56.05 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() APPLIED MOLECULAR TRANSPORT | Sell | $10.1M | -98.52% | NA | 0.0% |
![]() Moderna, Inc. | Buy | $49.1B | 586.61% | 11.46 | 31.77% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $79.5B | 139.69% | 19.72 | 33.81% |
![]() Seagen, Inc. | Hold | $36.7B | 217.59% | NA | -31.55% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $83.8B | 112.8% | 26.15 | 35.4% |
EPIQ Capital Group, LLC
Founders Fund V Management, LLC
Vanguard Group Inc
Founders Fund VI Management, LLC
BlackRock Inc
LAURION CAPITAL MANAGEMENT LP
APPLIED MOLECULAR TRANSPORT’s price-to-earnings ratio stands at None
Read MoreApplied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT's proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelium (IE) barrier. Active transport is an efficient mechanism that uses the cell's own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease. AMT's headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA.
Organization | APPLIED MOLECULAR TRANSPORT |
Employees | 15 |
CEO | Mr. Graham K. Cooper |
Industry | Health Technology |
ISHARES GSCI COMMODITY DYNAM
$25.58
+2.24%
ALPHA CAPITAL HOLDCO CO-A
$2.21
-1.34%
ESGEN ACQUISITION CORP.
$10.86
+0.0%
NuShares ESG Mid-Cap Value ETF
$27.65
+0.47%
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
$18.00
+1.24%
BLACKROCK MUNIVEST FUND
$6.67
+0.6%
TELESAT CORP
$7.06
+1.0%
FIRST TRUST MATERIALS ALPHAD
$58.46
+1.42%
James River Group Holdings Ltd
$19.07
-0.37%